NCT05516199

Brief Summary

In this pilot study, the investigators aim to examine if antenatal breastmilk expression from week 34 of pregnancy is a safe and feasible procedure for the mother and fetus. Furthermore, the investigators want to evaluate breastfeeding rates.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 11, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 25, 2022

Completed
6 days until next milestone

Study Start

First participant enrolled

August 31, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2023

Completed
Last Updated

January 16, 2024

Status Verified

January 1, 2024

Enrollment Period

1.1 years

First QC Date

August 11, 2022

Last Update Submit

January 11, 2024

Conditions

Keywords

Infant nutritionLactationBreastmilkBreastfeeding

Outcome Measures

Primary Outcomes (1)

  • Gestational age at birth in the two groups

    Gestational age of infant at birth. Information will be found through medical records. In the weekly push-messages the women have to answer if they have been giving birth. If they click yes, investigators get a notification and find gestational age and baseline infant characteristics through medical records.

    Through study completion, an avarage of 1 year.

Secondary Outcomes (5)

  • Number of weekly breastmilk expressions before birth

    Through study completion, an avarage of 1 year.

  • Amount of breastmilk expressed

    Through out the study, an average of 1 year. Assesment when all women included have been giving birth.

  • Breastfeeding rates 1, 2, 4 and 8 weeks after birth

    Through study completion, an avarage of 1 year.

  • Number of exclusively breastfeeding versus partially breastfeeding women in each group at 1, 2, 4 and 8 weeks after birth

    1, 2, 4 and 8 weeks after birth

  • Adverse reactions from mother or fetus during first breastmilk expression

    Through study completion, an avarage of 1 year.

Study Arms (2)

Antenatal breastmilk expression

EXPERIMENTAL

Breastfeeding consultation with trained midwife in week 33 + antenatal breastmilk expression from week 34

Behavioral: Antenatal breastmilk expressionBehavioral: Breastfeeding consultation

Control

OTHER

Breastfeeding consultation with trained midwife in week 33

Behavioral: Breastfeeding consultation

Interventions

Stimulation of the breast by hand/handexpression of breastmilk during pregnancy from week 34

Antenatal breastmilk expression

60 min standardized breastfeeding consultation with a trained midwife, with focus on practical breastfeeding skills

Antenatal breastmilk expressionControl

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsNo. They have to be able to be pregnant
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy nulliparous women with no major chronic or pregnancy related diseases
  • BMI \<27
  • Danish speaking
  • Singleton pregnancies
  • Planning to exclusively breastfeed their infants and deliver at Odense University Hospital (Odense and Svendborg)

You may not qualify if:

  • Suspected fetal intrauterine growth restriction or known major fetal anomaly
  • Women at risk of preterm birth with one of the following diagnoses: Placenta previa, premature preterm rupture of membranes (PPROM) or previous cervical conization
  • Women taking medications where breastfeeding is contraindicated
  • Women with prior breast surgery: Breast reductive surgery or breast implants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Odense University Hospital

Odense, 5000, Denmark

Location

Related Publications (19)

  • Ford SL, Lohmann P, Preidis GA, Gordon PS, O'Donnell A, Hagan J, Venkatachalam A, Balderas M, Luna RA, Hair AB. Improved feeding tolerance and growth are linked to increased gut microbial community diversity in very-low-birth-weight infants fed mother's own milk compared with donor breast milk. Am J Clin Nutr. 2019 Apr 1;109(4):1088-1097. doi: 10.1093/ajcn/nqz006.

    PMID: 30982856BACKGROUND
  • Wagner KJP, Rossi CE, Hinnig PF, Alves MA, Retondario A, Vasconcelos FAG. ASSOCIATION BETWEEN BREASTFEEDING AND OVERWEIGHT/OBESITY IN SCHOOLCHILDREN AGED 7-14 YEARS. Rev Paul Pediatr. 2021 Feb 24;39:e2020076. doi: 10.1590/1984-0462/2021/39/2020076. eCollection 2021.

    PMID: 33656144BACKGROUND
  • Laine MK, Kautiainen H, Gissler M, Pennanen P, Eriksson JG. Impact of gestational diabetes mellitus on the duration of breastfeeding in primiparous women: an observational cohort study. Int Breastfeed J. 2021 Feb 16;16(1):19. doi: 10.1186/s13006-021-00369-1.

    PMID: 33593367BACKGROUND
  • Victora CG, Bahl R, Barros AJ, Franca GV, Horton S, Krasevec J, Murch S, Sankar MJ, Walker N, Rollins NC; Lancet Breastfeeding Series Group. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet. 2016 Jan 30;387(10017):475-90. doi: 10.1016/S0140-6736(15)01024-7.

    PMID: 26869575BACKGROUND
  • Ballard O, Morrow AL. Human milk composition: nutrients and bioactive factors. Pediatr Clin North Am. 2013 Feb;60(1):49-74. doi: 10.1016/j.pcl.2012.10.002.

    PMID: 23178060BACKGROUND
  • Yu X, Li J, Lin X, Luan D. Association between Delayed Lactogenesis â…¡ and Early Milk Volume among Mothers of Preterm Infants. Asian Nurs Res (Korean Soc Nurs Sci). 2019 May;13(2):93-98. doi: 10.1016/j.anr.2019.02.001. Epub 2019 Feb 16.

    PMID: 30776448BACKGROUND
  • Underwood MA. Human milk for the premature infant. Pediatr Clin North Am. 2013 Feb;60(1):189-207. doi: 10.1016/j.pcl.2012.09.008. Epub 2012 Oct 18.

    PMID: 23178065BACKGROUND
  • Parker LA, Sullivan S, Krueger C, Mueller M. Association of timing of initiation of breastmilk expression on milk volume and timing of lactogenesis stage II among mothers of very low-birth-weight infants. Breastfeed Med. 2015 Mar;10(2):84-91. doi: 10.1089/bfm.2014.0089. Epub 2015 Feb 6.

    PMID: 25659030BACKGROUND
  • Forster DA, Moorhead AM, Jacobs SE, Davis PG, Walker SP, McEgan KM, Opie GF, Donath SM, Gold L, McNamara C, Aylward A, East C, Ford R, Amir LH. Advising women with diabetes in pregnancy to express breastmilk in late pregnancy (Diabetes and Antenatal Milk Expressing [DAME]): a multicentre, unblinded, randomised controlled trial. Lancet. 2017 Jun 3;389(10085):2204-2213. doi: 10.1016/S0140-6736(17)31373-9.

    PMID: 28589894BACKGROUND
  • Lopez-Fernandez G, Barrios M, Goberna-Tricas J, Gomez-Benito J. Breastfeeding during pregnancy: A systematic review. Women Birth. 2017 Dec;30(6):e292-e300. doi: 10.1016/j.wombi.2017.05.008. Epub 2017 Jun 19.

    PMID: 28642112BACKGROUND
  • Lamba S, Chopra S, Negi M. Effect of Antenatal Breast Milk Expression at Term Pregnancy to Improve Post Natal Lactational Performance. J Obstet Gynaecol India. 2016 Feb;66(1):30-4. doi: 10.1007/s13224-014-0648-7. Epub 2015 Jan 20.

    PMID: 26924904BACKGROUND
  • Foudil-Bey I, Murphy MSQ, Dunn S, Keely EJ, El-Chaar D. Evaluating antenatal breastmilk expression outcomes: a scoping review. Int Breastfeed J. 2021 Mar 12;16(1):25. doi: 10.1186/s13006-021-00371-7.

    PMID: 33712049BACKGROUND
  • Casey JRR, Banks J, Braniff K, Buettner P, Heal C. The effects of expressing antenatal colostrum in women with diabetes in pregnancy: A retrospective cohort study. Aust N Z J Obstet Gynaecol. 2019 Dec;59(6):811-818. doi: 10.1111/ajo.12966. Epub 2019 Mar 19.

    PMID: 30891743BACKGROUND
  • Demirci JR, Glasser M, Fichner J, Caplan E, Himes KP. "It gave me so much confidence": First-time U.S. mothers' experiences with antenatal milk expression. Matern Child Nutr. 2019 Oct;15(4):e12824. doi: 10.1111/mcn.12824. Epub 2019 May 23.

    PMID: 30950165BACKGROUND
  • Demirci J, Schmella M, Glasser M, Bodnar L, Himes KP. Delayed Lactogenesis II and potential utility of antenatal milk expression in women developing late-onset preeclampsia: a case series. BMC Pregnancy Childbirth. 2018 Mar 15;18(1):68. doi: 10.1186/s12884-018-1693-5.

    PMID: 29544467BACKGROUND
  • Soltani H, Scott AM. Antenatal breast expression in women with diabetes: outcomes from a retrospective cohort study. Int Breastfeed J. 2012 Dec 1;7(1):18. doi: 10.1186/1746-4358-7-18.

    PMID: 23199299BACKGROUND
  • Bruun S, Wedderkopp N, Molgaard C, Kyhl HB, Zachariassen G, Husby S. Using text messaging to obtain weekly data on infant feeding in a Danish birth cohort resulted in high participation rates. Acta Paediatr. 2016 Jun;105(6):648-54. doi: 10.1111/apa.13382. Epub 2016 Apr 13.

  • Simonsen MB, Bentzen SB, Moller S, Holm KG, Vinter CA, Zachariassen G. Safety of antenatal breastmilk expression from week 34 of pregnancy: a randomized controlled pilot study (The Express-MOM study). Matern Health Neonatol Perinatol. 2025 Jan 3;11(1):2. doi: 10.1186/s40748-024-00197-1.

  • Bentzen SB, Simonsen MB, Zachariassen G, Vinter CA, Garne Holm K. Women's bodily experience of antenatal breastmilk expression from 34 weeks of gestation: Qualitative results from the Express-MOM study. Eur J Midwifery. 2024 Nov 1;8. doi: 10.18332/ejm/193601. eCollection 2024.

MeSH Terms

Conditions

Breast Milk ExpressionBreast Feeding

Condition Hierarchy (Ancestors)

Feeding BehaviorBehavior

Study Officials

  • Marie B Simonsen, M.D

    OUH & SDU

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Parallel Assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 11, 2022

First Posted

August 25, 2022

Study Start

August 31, 2022

Primary Completion

September 30, 2023

Study Completion

November 30, 2023

Last Updated

January 16, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will share
Time Frame
Study protocol, SAP and ICF after protocol publication. CSR: After ended intervention and data collection
Access Criteria
Write to principal investigator to request data. Data will be transferred to Rigsarkivet Denmark if possible with regard to GDP regulations.

Locations